Kaplan Fox Encourages Gildan Activewear Inc. (NYSE: GIL) Investors Seeking Recovery to Contact the Firm Before December 14, 2026

Gildan shares fell $11.63, or 18.7%, to $50.34 on June 16, 2026, after short seller Jehoshaphat Research published allegations of channel stuffing and roughly $500 million in revenue pulled forward. A class action complaint alleges inadequate internal controls and that the company used channel stuffing to create an appearance of revenue; these are allegations, not established findings. Investors who acquired Gildan securities from February 19, 2025, through June 15, 2026, have until December 14, 2026, to seek lead-plaintiff status.

Analysis

The actionable risk is not the class-action filing itself; it is whether the short-seller allegation is corroborated by deteriorating cash conversion or a revenue-quality problem. A filing built on previously public allegations may add headline volatility but does not establish accounting misconduct, and the lead-plaintiff deadline is procedural rather than a merits catalyst. Avoid treating either as new proof.

If shipments were pulled forward, the second-order effect could be a period of weak replenishment from retailers, followed by lower factory utilization and less favorable fixed-cost absorption. That would make any revenue reversal more damaging to earnings than the top-line miss alone. Hanesbrands is a plausible apparel-basics peer to monitor for relative retailer ordering and inventory signals, but there is no basis here to assume it captures displaced Gildan demand.

Over days to weeks, expect headline and positioning risk; the June selloff means the original allegation is not new, so the incremental impact of this filing may be limited absent fresh evidence. Over 1–3 months, focus on receivables relative to sales, DSO, operating cash flow versus earnings, inventory at customers, and management/auditor commentary on controls. Over 6–18 months, verified revenue pull-forward could weigh on growth credibility and valuation even after reported sales normalize. Falsifiers include stable or improving cash conversion and receivables, evidence of retailer sell-through/reorders, and no control or guidance deterioration. A restatement, auditor issue, or sustained cash-flow divergence would materially strengthen the downside case.

Key Decisions for Investors

• Do not initiate a fresh short solely on this lawsuit announcement: it recycles allegations already associated with the June report, and the filing supplies no independent financial evidence.
• For existing GIL longs, keep exposure below normal event-risk size until the next reporting cycle clarifies receivables, DSO, operating cash flow, and customer inventory; reduce further if these metrics deteriorate or controls/auditor commentary worsens.
• Treat December 14 as a procedural monitoring date, not a fundamental catalyst. Reassess only if the lead-plaintiff process or subsequent filings introduce new, verifiable evidence.
• Watch Hanesbrands and broader apparel-basics order trends as a relative-demand check, not as an automatic pair trade; evidence of retailer inventory digestion across peers would weaken the claim that competitors can capture Gildan's potential lost orders.